Results 81 to 90 of about 1,043 (146)

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol. [PDF]

Cureus
Culpepper H, Overstreet M, Soliman K, Casey M, Rice T, Lively K, Scalea J, McGillicuddy J, Patel N, Taber D.   +9 more
europepmc   +1 more source

Beyond Thresholds: CMV Replication Kinetics as Early Predictors of Clinical Risk in Transplant Recipients. [PDF]

Infect Drug Resist
Kleiboeker HL, Descourouez JL, Saddler C, Jorgenson MR.   +3 more
europepmc   +1 more source

Targeting the US21 viroporin of human cytomegalovirus by calcium channel blockers as a new antiviral strategy. [PDF]

Curr Res Microb Sci
Sibille G, Loggia D, Catucci G, Gilardino A, Pla AF, Nardo GD, Munaron L, Gilardi G, Gribaudo G, Luganini A.   +9 more
europepmc   +1 more source

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. [PDF]

Immunotherapy
Wang Y, Wu J, Huang X, Xiao Y.
europepmc   +1 more source

Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation. [PDF]

Clin Infect Dis
Heldman MR, Boeckh MJ, Limaye AP.
europepmc   +1 more source

CMV infections after HSCT: prophylaxis and treatment. [PDF]

Blood Res
Chung H.
europepmc   +1 more source

Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. [PDF]

J Infect Dis
Chou S, Winston DJ, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Gu J, Pocock G, Papanicolaou GA.   +12 more
europepmc   +1 more source

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xuan L, Huang H, Xu LP, Fu YW, Chen F, Wang Y, Wang SQ, Dong L, Wu JY, Wu DP.   +9 more
europepmc   +1 more source

Recent advances in human cytomegalovirus: a comprehensive review of pathogenic mechanisms, virus-host interactions, and antiviral strategies. [PDF]

Front Immunol
Xia Y, Zhang J, Shui X, Wang C, Zhang S, Chai W, Yang Y, Shen L, Wang C.   +8 more
europepmc   +1 more source

Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy. [PDF]

Infect Chemother
Jang HM, Park HS, Sung H, Kim SH.
europepmc   +1 more source